142 related articles for article (PubMed ID: 3324992)
1. The specificity of serum antibodies to the haemagglutinin of influenza B viruses induced by vaccination.
Creţescu L; Ioniţă E; Niculescu IT; Coban V; Bogdan C
Arch Roum Pathol Exp Microbiol; 1987; 46(1):27-33. PubMed ID: 3324992
[No Abstract] [Full Text] [Related]
2. Characteristic of humoral response of elderly to inactivated influenza vaccine.
Siennicka J
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
[TBL] [Abstract][Full Text] [Related]
3. [The immunological shifts in the blood sera of persons inoculated with influenza vaccines].
Stepanovskaia LD; Solomko RM; Avratinskiĭ IM; Katuntsevskaia GP; Kiriliuk ZhI; Iampol'skiĭ MP; Burdeniuk EI
Mikrobiol Zh (1978); 1992; 54(4):70-5. PubMed ID: 1406385
[TBL] [Abstract][Full Text] [Related]
4. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
Schmidt S; Süss J; Oehring H; Schmidt J
Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
[TBL] [Abstract][Full Text] [Related]
6. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
Oxford JS; Schild GC; Potter CW; Jennings R
J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in human sera after vaccination with inactivated influenza vaccine.
Loza-Tulimowska M; Semkow R; Michalak T; Wilczyński J
Acta Virol; 1979 Mar; 23(2):159-61. PubMed ID: 39440
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I.
Ioniţă E; Lupulescu E; Alexandrescu V; Maţepiuc M; Constantinescu C; Creţescu L; Velea L
Arch Roum Pathol Exp Microbiol; 1989; 48(3):265-73. PubMed ID: 2519636
[TBL] [Abstract][Full Text] [Related]
9. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
Brydak L; Rudnicka H
Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
[TBL] [Abstract][Full Text] [Related]
11. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
Ennis FA; Yi-Hua Q; Schild GC
J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
[TBL] [Abstract][Full Text] [Related]
12. [Testing of influenza virus vaccines--an international comparison].
Klett G; Stäber H; Willkommen H
Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
[No Abstract] [Full Text] [Related]
13. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
Unanov SS; Yuminova NV; Akopova II
Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of inactivated influenza vaccine containing A/Niigata/102/81 (H3N2). Increase of HAI antibodies to different variants of the subtype.
Takeuchi Y; Takahashi M; Satsuta K; Hatta S; Suzuki H; Ogawa Y; Hirano S; Takahashi K; Yamazi Y
Nihon Ika Daigaku Zasshi; 1985 Oct; 52(5):607-10. PubMed ID: 4066903
[No Abstract] [Full Text] [Related]
15. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
Stech J
Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
[TBL] [Abstract][Full Text] [Related]
16. [Live influenza vaccine].
Smorodintsev AA
Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
[No Abstract] [Full Text] [Related]
17. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
18. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
[TBL] [Abstract][Full Text] [Related]
19. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
Stumpa A; Tůmová B
Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
[No Abstract] [Full Text] [Related]
20. [Vaccinal prevention of influenza in children].
Zykov MP; Vasil'eva RI
Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
